{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:03:32Z","timestamp":1790503412237,"version":"4.1.0"},"reference-count":30,"publisher":"European Respiratory Society (ERS)","issue":"1","content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2015,1,7]]},"published-print":{"date-parts":[[2015,7]]},"abstract":"<jats:p>Testing for latent tuberculosis infection (LTBI) in HIV-infected persons in low tuberculosis (TB) incidence areas is often recommended. Using contemporary, clinical data, we report the yield and cost-effectiveness of testing all HIV attendees, two current UK strategies and no LTBI testing.<\/jats:p><jats:p>Economic modelling was performed utilising 10-year follow up data from a large HIV clinical cohort. Outcomes were numbers of cases of active TB and incremental cost per quality-adjusted life year (QALY) gained.<\/jats:p><jats:p>Between 2000 and 2010, 256 people were treated for TB\/HIV co-infection. 72 (28%) occurred \u22653\u2005months after HIV diagnosis and may have been prevented by LTBI testing. Between 2000 and 2005, the incremental cost per QALY gained for the British HIV Association (BHIVA) and UK National Institute of Care Excellence (NICE) strategies, and testing all clinic attendees was \u20ac6270, \u20ac6998 and \u20ac33\u200a473, respectively. These rose to \u20ac9332, \u20ac32\u200a564 and \u20ac74\u200a067, respectively, between 2005 and 2010. Probabilistic sensitivity analysis suggested that at a threshold of \u20ac24\u200a000 per additional QALY, the most cost-effective strategies would be NICE or testing all in 2000\u20132005 and BHIVA during 2005\u20132010.<\/jats:p><jats:p>Both UK testing regimens missed cases but are cost-effective compared with no testing. Using recent data, they all became more expensive, suggesting that alternative or more targeted TB testing strategies must be considered.<\/jats:p>","DOI":"10.1183\/09031936.00067114","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T01:52:39Z","timestamp":1429235559000},"page":"165-174","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Decreasing cost effectiveness of testing for latent TB in HIV in a low TB incidence area"],"prefix":"10.1183","volume":"46","author":[{"given":"Santino","family":"Capocci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Bhagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Cropley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Abubakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lipman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2015,4,16]]},"reference":[{"key":"2024102023271295000_46.1.165.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530020061033"},{"key":"2024102023271295000_46.1.165.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08904-3"},{"key":"2024102023271295000_46.1.165.3","doi-asserted-by":"crossref","unstructured":"Akolo C , Adetifa I , Shepperd S , et al. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2010: CD000171.","DOI":"10.1002\/14651858.CD000171.pub3"},{"key":"2024102023271295000_46.1.165.4","unstructured":"Tuberculosis in the UK: 2014 report. London: Public Health England. www.gov.uk\/government\/publications\/tuberculosis-tb-in-the-uk Date last updated: Sept 25, 2014. Date last accessed: Nov 1, 2014."},{"key":"2024102023271295000_46.1.165.5","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00198813"},{"key":"2024102023271295000_46.1.165.6","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00044314"},{"key":"2024102023271295000_46.1.165.7","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00205512"},{"key":"2024102023271295000_46.1.165.8","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00216613"},{"key":"2024102023271295000_46.1.165.9","unstructured":"European Centre for Disease Prevention and Control. Progressing towards TB elimination. Stockholm, ECDC, 2010."},{"key":"2024102023271295000_46.1.165.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2011.00954.x"},{"key":"2024102023271295000_46.1.165.11","unstructured":"NICE. Tuberculosis - Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. NICE Clinical Guideline 117, 2011. Available from: www.nice.org.uk\/guidance\/cg117\/resources\/guidance-tuberculosis-pdf Date last accessed: Jan 17, 2012."},{"key":"2024102023271295000_46.1.165.12","unstructured":"European AIDS Clinical Society Guidelines for the diagnosis and treatment of resistant and latent TB in HIV positive persons 2014. Available from: www.eacsociety.org\/files\/guidelines_english_71_141204.pdf Date last accessed: July 15, 2014."},{"key":"2024102023271295000_46.1.165.13","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283320dfd"},{"key":"2024102023271295000_46.1.165.14","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328216f441"},{"key":"2024102023271295000_46.1.165.15","unstructured":"Health Protection Agency. HIV in the United Kingdom: 2011 Report. London: Health Protection Services, Colindale. November 2011. Available from: http:\/\/webarchive.nationalarchives.gov.uk\/20140629102648\/ http:\/\/www.hpa.org.uk\/webc\/HPAwebFile\/HPAweb_C\/1317131685847 Date last accessed: June 12, 2012. Date last updated: Jan20, 2012."},{"key":"2024102023271295000_46.1.165.16","unstructured":"HIV prevalence greatest in London boroughs but quality of care is high. Health Protection Agency, Colindale. November 2010. Available from: http:\/\/webarchive.nationalarchives.gov.uk\/20140714084352\/ http:\/\/www.hpa.org.uk\/ProductsServices\/LocalServices\/London\/LondonPressReleases\/lond101126HIVprevalencegreatestinLondon\/ Date last updated: June 15, 2011. Date last accessed: June 18, 2012."},{"key":"2024102023271295000_46.1.165.17","unstructured":"Health Protection Agency. HPA HPP single map for rate of tuberculosis diagnoses per 100,000 population, Camden; London. Available from: http:\/\/profiles.hpa.org.uk\/IAS\/dataviews\/report?reportId=4&viewId=7&geoId=8&geoSubsetId=&select=00AG Date last accessed: July 10, 2012."},{"key":"2024102023271295000_46.1.165.18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-107"},{"key":"2024102023271295000_46.1.165.19","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-7-56"},{"key":"2024102023271295000_46.1.165.20","doi-asserted-by":"publisher","DOI":"10.1086\/597351"},{"key":"2024102023271295000_46.1.165.21","unstructured":"National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. Guide to the methods of technology appraisal. 2008, Jun; Available from: www.nice.org.uk\/media\/b52\/a7\/tamethodsguideupdatedjune2008.pdf Date last updated: Jun 2008. Date last accessed: Feb 21, 2013."},{"key":"2024102023271295000_46.1.165.22","doi-asserted-by":"publisher","DOI":"10.1086\/510080"},{"key":"2024102023271295000_46.1.165.23","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32835e2cb1"},{"key":"2024102023271295000_46.1.165.24","first-page":"1203","article-title":"Tolerability of anti-tuberculosis treatment and HIV serostatus","volume":"11","author":"Lanternier","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102023271295000_46.1.165.25","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200201040-00010"},{"key":"2024102023271295000_46.1.165.26","first-page":"417","article-title":"High level of discordant IGRA results in HIV-infected adults and children","volume":"12","author":"Mandalakas","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102023271295000_46.1.165.27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-9-15"},{"key":"2024102023271295000_46.1.165.28","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283188415"},{"key":"2024102023271295000_46.1.165.29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029775"},{"key":"2024102023271295000_46.1.165.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2007.03477.x"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/09031936.00067114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:57:12Z","timestamp":1740380232000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/09031936.00067114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,16]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,6,30]]},"published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.1183\/09031936.00067114"],"URL":"https:\/\/doi.org\/10.1183\/09031936.00067114","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,16]]}}}